1. Capturing the Diversity of Dermatology—What’s in a Name?

   • Taylor Erickson
   • Karishma Daftary
   • Raj Chovatiya

   Current Opinion 16 June 2023 Pages: 675 - 680

   

2. Targeting Inflammation in Acne: Current Treatments and Future Prospects

   • Sebastian Cruz
   • Natalia Vecerek
   • Nada Elbuluk

   Leading Article Open access 16 June 2023 Pages: 681 - 694

3. Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review

   • Jonathan K. Hwang
   • Jose W. Ricardo
   • Shari R. Lipner

   Systematic Review 20 May 2023 Pages: 695 - 720

   

4. Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis

   • Chia-Ling Yu
   • Po-Yi Chou
   • Ching-Chi Chi

   Systematic Review 03 April 2023 Pages: 721 - 730

   

5. Atopic Dermatitis Across Shades of Skin

   • Victor L. Quan
   • Taylor Erickson
   • Raj Chovatiya

   Review Article 19 June 2023 Pages: 731 - 751

   

6. Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

   • Diana Bernardo
   • Thomas Bieber
   • Tiago Torres

   Review Article Open access 02 June 2023 Pages: 753 - 764

   

7. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies

   • Christopher J. Fay
   • Samantha Jakuboski
   • Nicole R. LeBoeuf

   Review Article 03 July 2023 Pages: 765 - 785

   

8. Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial

   • Elaine C. Siegfried
   • Michael J. Cork
   • Annie Zhang

   Original Research Article Open access 10 June 2023 Pages: 787 - 798

   

9. Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study

   • Hao-Hsin Huang
   • Dereck Shen
   • Chia-Yu Chu

   Original Research Article 06 June 2023 Pages: 799 - 808

   

10. Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome

    • Philip J. Mease
    • Gülen Hatemi
    • Linda Stein Gold

    Original Research Article Open access 14 June 2023 Pages: 809 - 820

    

11. Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials

    • Michael Sticherling
    • Arjen F. Nikkels
    • Deborah Keefe

    Original Research Article Open access 21 June 2023 Pages: 821 - 835

12. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

    • Tadashi Terui
    • Yukari Okubo
    • Masamoto Murakami

    Original Research Article Open access 26 May 2023 Pages: 837 - 847

    

13. The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights

    • Kathy A. Fraser

    Meeting Report 21 August 2023 Pages: 849 - 851

14. Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

    • Shurong Chen
    • Yi Chen

    Letter to the Editor 27 June 2023 Pages: 853 - 854

15. Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”

    • Chia-Ling Yu
    • Po-Yi Chou
    • Ching-Chi Chi

    Letter to the Editor 27 June 2023 Pages: 855 - 858